- Report
- January 2022
- 105 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- August 2023
- 102 Pages
Global
From €3249EUR$3,325USD£2,712GBP
€4641EUR$4,750USD£3,874GBP
- Report
- November 2023
- 30 Pages
Global
From €2223EUR$2,275USD£1,856GBP
€3175EUR$3,250USD£2,651GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- August 2022
- 78 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- August 2022
- 157 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Report
- August 2022
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- January 2022
- 90 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Report
- January 2022
- 90 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 200 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Report
- August 2024
- 80 Pages
Japan
From €3420EUR$3,500USD£2,855GBP
- Report
- November 2023
- 171 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- October 2023
- 189 Pages
Global
From €4397EUR$4,500USD£3,671GBP
The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue.
Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection.
Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more